Trials
Stopped before inclusion studies
Read about our projects
-
No information available
See details -
Effectiveness of Zometa® treatment for the prevention of bone metastases in high risk prostate cancer patients. A randomized, open-label, multicenter study of the European Association of Urology (EAU) in cooperation with the Scandinavian Prostate Cancer Group (SPCG) and the Arbeitsgemeinschaft Urologische Onkologie (AUO)
See details -
Cancelled trial due to Socialstyrelsen in Sweden
See details